These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9183659)

  • 1. Telomerase in hepatocellular carcinogenesis.
    Ide T; Tahara H; Nakashio R; Kitamoto M; Nakanishi T; Kajiyama G
    Hum Cell; 1996 Dec; 9(4):283-6. PubMed ID: 9183659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of telomerase activity in resected hepatocellular carcinoma.
    Kanamaru T; Yamamoto M; Morita Y; Itoh T; Kuroda Y; Hisatomi H
    Int J Mol Med; 1999 Sep; 4(3):267-71. PubMed ID: 10425277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase as a tool for the differential diagnosis of human hepatocellular carcinoma.
    Nouso K; Urabe Y; Higashi T; Nakatsukasa H; Hino N; Ashida K; Kinugasa N; Yoshida K; Uematsu S; Tsuji T
    Cancer; 1996 Jul; 78(2):232-36. PubMed ID: 8673997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of telomerase activity in hepatocellular carcinoma.
    Ohta K; Kanamaru T; Yamamoto M; Saitoh Y
    Kobe J Med Sci; 1996 Jun; 42(3):207-17. PubMed ID: 8973088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of telomerase activity in the diagnosis of small hepatocellular carcinoma].
    Higashi T; Nouso K; Tsuji T
    Nihon Rinsho; 1998 May; 56(5):1248-52. PubMed ID: 9613132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.
    Tahara H; Nakanishi T; Kitamoto M; Nakashio R; Shay JW; Tahara E; Kajiyama G; Ide T
    Cancer Res; 1995 Jul; 55(13):2734-6. PubMed ID: 7796395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Telomerase activity in liver cancer and the adjacent tissue].
    Fu J; Zhang W; Jin S
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):434-6. PubMed ID: 10920937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues.
    Kawakami Y; Kitamoto M; Nakanishi T; Yasui W; Tahara E; Nakayama J; Ishikawa F; Tahara H; Ide T; Kajiyama G
    Oncogene; 2000 Aug; 19(34):3888-93. PubMed ID: 10951582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity and telomerase catalytic subunit in hepatocellular carcinoma.
    Lee CM; Hsu CY; Eng HL; Huang WS; Lu SN; Changchien CS; Chen CL; Cho CL
    Hepatogastroenterology; 2004; 51(57):796-800. PubMed ID: 15143919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma.
    Ogami M; Ikura Y; Nishiguchi S; Kuroki T; Ueda M; Sakurai M
    Lab Invest; 1999 Jan; 79(1):15-26. PubMed ID: 9952107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Telomere length and telomerase activity in hepatocellular carcinoma].
    Nakashio R; Kitamoto M; Nakanishi T; Takaishi H; Takahashi S; Kajiyama G
    Nihon Rinsho; 1998 May; 56(5):1239-43. PubMed ID: 9613130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
    Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G
    Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of telomerase activity in precancerous lesion of the liver (adenomatous hyperplasia)].
    Nishimoto A; Miura N; Oshimura M
    Nihon Rinsho; 1998 May; 56(5):1244-7. PubMed ID: 9613131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific molecular markers in hepatocellular carcinoma.
    Yao DF; Dong ZZ; Yao M
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):241-7. PubMed ID: 17548245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma.
    Nakashio R; Kitamoto M; Tahara H; Nakanishi T; Ide T; Kajiyama G
    Int J Cancer; 1997 Apr; 74(2):141-7. PubMed ID: 9133446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma.
    Tsutsumi M; Sakamuro D; Takada A; Zang SC; Furukawa T; Taniguchi N
    Hepatology; 1996 May; 23(5):1093-7. PubMed ID: 8621139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal expression of hepatomas and circulating telomerase and its clinical values.
    Wu W; Yao DF; Qiu LW; Wu XH; Yao M; Su XQ; Zou L
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):544-9. PubMed ID: 16286259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase activity in precancerous hepatic nodules.
    Hytiroglou P; Kotoula V; Thung SN; Tsokos M; Fiel MI; Papadimitriou CS
    Cancer; 1998 May; 82(10):1831-8. PubMed ID: 9587114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
    Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
    Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
    Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
    J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.